Shenzhen Kangtai Biological Products Co., Ltd.
SZSE:300601.SZ
28.75 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| 861.304 | -132.708 | 1,263.377 | 679.186 | 574.506 | 435.685 | 214.703 | 86.214 | 62.822 | 31.163 | 1.511 | 11.448 |
| Depreciation & Amortization
| 240.716 | 200.948 | 404.71 | 92.933 | 82.982 | 57.907 | 57.872 | 45.754 | 50.248 | 48.872 | 48.416 | 32.73 |
| Deferred Income Tax
| 78.96 | -205.539 | 50.66 | 93.224 | 20.394 | -36.18 | -33.371 | -15.222 | -3.248 | 0 | 0 | 0 |
| Stock Based Compensation
| 3.191 | 4.733 | 29.954 | 104.815 | 131.894 | 51.077 | 20.436 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -392.802 | -604.528 | -275.586 | -461.748 | -292.677 | -180.943 | -141.877 | -77.699 | 151.423 | 3.495 | -57.244 | -55.29 |
| Accounts Receivables
| -417.175 | -488.759 | 273.876 | -796.492 | -178.328 | -365.282 | -249.448 | -139.543 | -20.696 | -40.273 | -43.958 | -8.913 |
| Inventory
| 8.676 | 220.745 | -746.666 | -209.733 | -31.895 | -2.232 | -53.221 | -29.707 | 40.17 | 5.788 | -20.054 | -18.661 |
| Accounts Payables
| 18.888 | -130.975 | 146.544 | 451.253 | -102.848 | 222.751 | 194.162 | 106.772 | 135.197 | 0 | 0 | 0 |
| Other Working Capital
| -3.191 | -205.539 | 50.66 | 93.224 | 20.394 | -178.711 | -88.657 | -47.992 | 111.253 | -2.293 | -37.19 | -36.629 |
| Other Non Cash Items
| 1,176.59 | 1,277.551 | 179.155 | -68.562 | -11.396 | 23.827 | 23.287 | 24.055 | 13.362 | 28.529 | 33.703 | 16.365 |
| Operating Cash Flow
| 1,093.725 | 545.696 | 1,652.27 | 439.847 | 505.702 | 336.476 | 153.985 | 78.324 | 277.855 | 112.059 | 26.385 | 5.253 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -718.451 | -1,310.392 | -2,540.415 | -1,226.66 | -386.627 | -343.697 | -189.638 | -171.632 | -118.673 | -89.351 | -129.892 | -68.74 |
| Acquisitions Net
| 0.961 | 0.08 | 0.186 | 1,227.675 | 0.239 | 0.786 | 189.667 | 171.632 | 118.704 | 100.352 | 129.892 | 0 |
| Purchases Of Investments
| -820 | -3,518 | -1,100 | -2,625 | -0.239 | 0 | -73.2 | -6.8 | -9 | -11 | -14.5 | 0 |
| Sales Maturities Of Investments
| 1,038 | 2,224.381 | 2,198.2 | 13.731 | 6.685 | 106.774 | 1.88 | 0.767 | 2.685 | 5.012 | 1.435 | 0 |
| Other Investing Activites
| 279.584 | -2.373 | 1.728 | -1,226.66 | 0.239 | 0.786 | -189.638 | -171.632 | -118.673 | -89.351 | -129.892 | 0.003 |
| Investing Cash Flow
| -499.49 | -2,606.304 | -1,440.303 | -3,836.914 | -379.703 | -236.138 | -260.928 | -177.666 | -124.957 | -84.339 | -142.956 | -68.737 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -80.48 | -1,070.438 | -26.477 | -256.018 | -68.839 | -65.93 | -120.923 | -118.961 | -279.852 | -168.348 | -93.491 | -115 |
| Common Stock Issued
| -159.063 | 132.7 | -2.103 | -0.987 | 0.196 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| -100.992 | -20.552 | 2.103 | -0.21 | -0.196 | -0.277 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -201.044 | -595.259 | -206.11 | -69.67 | -43.813 | -64.095 | -43.087 | -17.788 | -24.556 | -31.244 | -31.764 | -28.151 |
| Other Financing Activities
| -37.435 | 1,115.567 | 2,699.045 | 4,243.252 | 20.177 | 461.823 | 310.86 | 192.919 | 78.552 | 317.202 | 101.706 | 317.571 |
| Financing Cash Flow
| -418.054 | -464.876 | 2,452.151 | 3,778.712 | -226.736 | 331.798 | 146.85 | 56.17 | -225.856 | 117.61 | -23.549 | 174.42 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0.035 | -1.663 | -0.979 | -0.039 | 0.008 | 0.044 | -0.028 | 0 | -0.003 | -0.003 | 0.002 | 0.004 |
| Net Change In Cash
| 177.961 | -2,527.147 | 2,663.14 | 381.606 | -100.731 | 432.181 | 39.878 | -43.172 | -72.961 | 145.327 | -140.118 | 110.94 |
| Cash At End Of Period
| 1,195.582 | 994.109 | 3,521.256 | 858.116 | 476.51 | 577.241 | 145.06 | 105.182 | 148.354 | 221.315 | 75.988 | 216.106 |